Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05558059 · ClinicalTrials.gov registry record
Imaging Retinal Vasculature in Infant Eyes
A clinical trial of Retinopathy of Prematurity, sponsored by Duke University.
- Recruiting
- Registry status
- 16
- Enrollment target
- 2
- Study locations
NCT05558059: Recruiting study of Retinopathy of Prematurity, sponsored by Duke University.
NCT05558059 is a study of Retinopathy of Prematurity that is actively recruiting participants, run by Duke University. The registered enrollment target is 16 participants, below the 367-participant average among 7 other Retinopathy of Prematurity trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05558059, a study of Retinopathy of Prematurity, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 16 participants
- Enrollment target
- 2
- Study locations
Study Summary
Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a critical location in the retina determining visual acuity and visual function, and the blood vessels around it, are abnormally developed in infants with retinopathy of prematurity. However, how these blood vessels form during development of the human fovea remains unclear. This research will advance our understanding of the fundamental knowledge of how the blood vessels around the fovea form in infants, and how they change in diseased states such as preterm birth or retinopathy of prematurity.
Primary Outcome
Measured by retinal OCTA imaging.
Conditions Studied
Interventions
- DEVICE Handheld Optical Coherence Tomography with OCT Angiography
Study Locations (2)
North Carolina
- Duke University - Durham
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2027-08-31 |
What NCT05558059 shows while recruiting
NCT05558059 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 367-participant average among 7 other Retinopathy of Prematurity trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Retinopathy of Prematurity appearing as the primary indexed condition, and to 1 intervention - of which Handheld Optical Coherence Tomography with OCT Angiography is the first listed.
NCT05558059 reports a single indexed study location in North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05558059 about?
NCT05558059 is a clinical study titled "Imaging Retinal Vasculature in Infant Eyes". Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a critical location in the retina determining visual acuity and visual function, and the blood vessels around it, are abnormally developed in infants with retinopathy of prematurity. However, how these blood v...
What is the current status of trial NCT05558059?
This trial is currently recruiting. The enrollment target is 16 participants. The study started on 2024-10-03. Estimated completion is 2027-08-31.
What conditions does trial NCT05558059 study?
This clinical trial studies the following conditions: Retinopathy of Prematurity.
What interventions are being tested in trial NCT05558059?
The interventions under investigation include: Handheld Optical Coherence Tomography with OCT Angiography (DEVICE).
Who is sponsoring clinical trial NCT05558059?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05558059 being conducted?
This trial has 2 study locations across North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinopathy of Prematurity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical and Genetic Analysis of ROP
RECRUITING
-
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
RECRUITING · NA
-
Bevacizumab Treatment For Type 1 ROP
ACTIVE NOT RECRUITING · Phase 2
-
Validation of i-ROP DL to Detect More Than Mild ROP
ACTIVE NOT RECRUITING · NA
-
Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)
ACTIVE NOT RECRUITING
-
The Effects of Light Reduction on Retinopathy of Prematurity (Light-ROP)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI